In addition to these studies demonstrating the role of HER2/neu in gynecological cancers, Zhang et al. reported that overexpression of human HIV-1 TAT interactive protein 2 (HTATIP2/TIP30) is associated with HER2/neu status in breast cancer [10]. Here, ERBB2 is linked to breast carcinoma.